Meeting News Coverage

Seeing clogged arteries helps patients adhere to statin therapy, weight loss efforts

April 5, 2012
It helps for people to actually see the images of their own clogged arteries after undergoing coronary artery calcium scoring with cardiac computed…
Meeting News Coverage

Statin linked to increased myalgia

Endocrine Today, April 2012
CHICAGO — Individuals taking atorvastatin were twice as likely to report symptoms of myalgia as compared with individuals taking placebo, according…
Meeting News CoveragePerspective

Two studies show promising, durable results for renal denervation

Endocrine Today, April 2012
CHICAGO — The Symplicity renal denervation system provided reductions in blood pressurethat were sustained for up to 3 years in patients with …
Meeting News CoveragePerspective

Novel monoclonal antibody lowers LDL, may supplement statin therapy

Endocrine Today, April 2012
CHICAGO — A novel monoclonal antibody identified in a new study dramatically lowered circulating LDL by 40% to 72%, a development researchers said…
Meeting News Coverage

Lifelong reductions in LDL linked to consistent reduction in CHD risk

March 26, 2012
CHICAGO — Individuals with lower LDL levels beginning early in life were much less likely to develop CHD, according to data presented here…
Meeting News CoveragePerspective

Bariatric surgery bested medical therapy for managing obese patients with diabetes

March 26, 2012
CHICAGO — Bariatric surgery was significantly more effective than intensive medical therapy alone in achieving glycemic control in obese patients…
Meeting News Coverage

Expert discusses past, present and future of MI care

Endocrine Today, April 2012
CHICAGO — In 1912, James Herrick, MD, published the first paper describing the clinical features of two patients with MI. As 2012 marks the…
Meeting News Coverage

Inverse relationship between LDL levels, cancer diagnosis identified

March 25, 2012
CHICAGO — Researchers identified an inverse relationship between LDL levels and cancer that persisted for more than 18 years before cancer…
Meeting News Coverage

RESOLUTE US: Zotarolimus-eluting stent continues to perform at 2 years

March 25, 2012
CHICAGO — The Resolute Integrity zotarolimus-eluting stent demonstrated ongoing efficacy out to 2 years in a broad range of US patients, including…
Meeting News Coverage

Microvascular dysfunction common in patients referred for stress testing

Endocrine Today, April 2012
CHICAGO — Men and women who had been referred for stress testing had similar rates of impaired coronary flow reserve, with microvascular …